AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the population, with around 30% in the U.S. and 25% globally experiencing this condition. NAFLD occurs when fat accumulates in the liver without significant alcohol consumption, and it can manifest as simple steatosis without liver cell damage or as non-alcoholic steatohepatitis (NASH), which involves liver cell damage. Regular blood work is essential to monitor liver enzymes like AST and ALT, as elevated levels can indicate liver health issues that often go undiagnosed, increasing risks for severe health complications. Being proactive with diagnostic tests, including ultrasounds or MRI scans, can help catch this disease at an earlier, more manageable stage.